Issue
Title
Authors
Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2
Chazova I.E., Shestakova M.V., Zhernakova Y.V., Markova T.N., Mazurina N.V., Yezhov M.V., Mironova O.Y., Litvin A.Y., Elfimova E.M., Blinova N.V., Sukhareva O.Y., Ametov A.S., Akhmedzhanov N.M., Kislyak O.A., Kukharchuk V.V., Nedogoda S.V., Nebieridze D.V., Medvedev I.V., Mkrtumyan A.M., Podzolkov V.I.
Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population
Ostroumova O.D., Cherniaeva M.S.
Drug-induced arterial hypertension
Ostroumova O.D., Kulikova M.I.
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension
Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E.
Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis
Yudkina N.N., Valeeva E.G., Taran I.N., Nikolaeva E.V., Paramonov V.M., Kurmukov I.A., Valieva Z.S., Arkhipova O.A., Martynyuk T.V., Volkov A.V., Nasonov E.L., Chazova I.E.
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E.
Possibilities of treatment of patients with resistant arterial hypertension
Shugushev Z.K., Maximkin D.A., Ryumina A.S.
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
Zhernakova Y.V., Chazova I.E.
Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)
Oshchepkova E.V., Lazareva N.V., Chazova I.E.
Features of the use of torasemide in arterial hypertension
Baryshnikova G.A., Chorbinskajya S.A.
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy
Oshchepkova E.V., Avalyan A.A., Rogoza A.N., Gorieva S.B., Saidova M.A., Chazova I.E.
Workplace hypertension": focus on emotional and personality traits in patients
Ostroumova O.D., Pervichko E.I., Zinchenko Y.P.
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology
Dolgova E.V., Fedorovich A.A., Martynyuk T.V., Rogoza A.N., Chazova I.E.
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension
Arkhipova O.A., Gratsianskaya S.E., Martynyuk T.V.
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
Arkhipova O.A., Martynyuk T.V.
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T.
Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system
Mozheyko M.E., Eregin S.Y., Vigdorchik A.V., Klimovskaia I.M., Riahi F., Hughes D.
Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine
Kuznetsova E.G., Glukhova S.I., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E.
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice
Gratsianskaya S.E., Valieva Z.S., Zorin A.V., Martynyuk T.V.
Myocardial ischemia in patients with pulmonary arterial hypertension
Arkhipova O.A., Martyniuk T.V., Valeeva E.G., Ryabykina G.V., Samoylenko L.E., Sergienko V.B., Chazova I.E.
The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea
Elfimova E.M., Zairova A.R., Andrievskaya M.V., Bogieva R.M., Rogoza A.N., Litvin A.Y.
Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Titarenko M.N.
Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case
Bykov A.N., Arkhipov M.V., Klimusheva N.F., Iofin A.I., Krokhalev V.Y.
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy
Ostroumova O.D., Kochetkov A.I., Lopukhina M.V.
Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension
Shchelkova G.V., Zairova A.R., Danilov N.M., Rogoza A.N., Chazova I.E.
The nature of the course of arterial hypertension in low-renin hyperaldosteronism
Chikhladze N.M.
The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008
Chazova I.E., Ratova L.G., Chazova I.E., Ratova L.G.
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
Chazova I.Y., Zhernakova Y.V., Blinova N.V., Rogoza A.N.
Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
Aksenova A.V., Elfimova E.M., Litvin A.Y., Chazova I.E.
The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome
Skibickiy V.V., Fendrikova A.V., Skibickiy A.V., Syrotenko D.V.
Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders
Gorokhovskaya G.N., Yun V.L.
Use of diuretics in hypertensive patients with metabolic disturbances
Zhernakova Y.V., Chazova I.E.
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
Chazova I.E., Ostroumova O.D.
Features of diurnal blood pressure profile, arterial stiffness and left ventricular structure and function in patients with arterial hypertension, prediabetes and type 2 diabetes mellitus
Fendrikova A.V., Gutova S.R., Skibitsky V.V., Skibitsky A.V.
Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up
Gapon L.I., Mikova E.V., Savelyeva N.Y., Kolunin G.V., Zherzhova A.Y.
Current possibilities of nuclear imaging in arterial hypertension
Ansheles A.A., Sergienko V.B.
Perindopril - angiotensin-converting enzyme inhibitor is approved for usage
Napalkov D.A.
The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk
Mordvinova E.V., Oschepkova E.V., Fedorovich A.A., Rogoza A.N.
The availability of a home tonometer as a factor that increases therapy compliance in outpatients with arterial hypertension
Smirnova M.D., Tsygareishvili E.V., Ageyev F.T., Svirida O.N., Kuzmina A.E., Fofanova T.V.
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice
Martynyuk T.V., Kolos I.P., Chazova I.E., Martyniuk T.V., Kolos I.P., Chazova I.E.
Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin
Nedogoda S.V., Chumachek E.V., Ledyaeva A.A., Tsoma V.V., Salasyuk A.S., Smirnova V.O., Khripaeva V.Y., Palashkin R.V., Popova E.A.
Perindopril is angiotensin-converting enzyme inhibitor in treatment patients with arterial hypertension
Martynov A.I., Urlaeva I.V., Akatova Y.V., Nikolin O.P.
The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency
Shiganov S.V., Baev V.V., Shulbayev A.P.
Amlodipin in the treatment of arterial hypertension
Galyavich A.S.
Combined antihypertensive therapy in the light of modern recommendations: strategy of one tablet
Morozova T.E.
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
Avalyan A.A., Kirillova M.Y., Shitov V.N., Oshchepkova Y.V., Saidova M.A., Stenina M.B., Chazova I.Y.
The role of beta-blockers in the treatment of arterial hypertension: what do we know today
Zhernakova Y.V., Chazova I.E.
The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience
Gilyarevsky S.R.
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome
Nedogoda S.V., Salasyuk A.S., Chalyabi T.A., Barykina I.N., Pocheptsov D.A., Ledyaeva A.A., Tsoma V.V., Chumachek E.V.
Rationale for the use of sartans in patients with arterial hypertension
Stryuk R.I.
The progression of carotid vascular remodeling risk factors in patients with arterial hypertension
Pavlova O.S., Korobko I.Y., Nechesova T.A., Liventseva M.M., Zatoloka N.V., Kovsh E.V., Ogurtsova S.E., Mrochek A.G.
Dihydropyridine calcium antagonists: conscious choice
Ostroumova O.D., Vikentev V.V., Abrosimov A.G., Smoliarchuk E.A.
Using meldonium to improve adaptation of patients with hypertension and pre-diabetes to influence of heat
Smirnova M.D., Svirida O.N., Ageev F.T., Fofanova T.V., Vitsenya M.V., Mikhaylov G.V.
Arterial hypertension and brain damage. New targets of therapy
Yanishevskiy S.N., Mirnaya D.A., Andreyev R.V.
The telmisartan and amlodipine combination in the treatment of hypertension
Shehyan G.G., Yalymov A.A., Schikota A.M., Zadionchenko V.S., Varentsov S.I.
The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)
Chazova I.E., Chuchalin A.G., Zykov K.A., Ratova L.G.
New approaches to the analysis of daily variability of sinus rhythm in assessing the antihypertensive effect of various drugs
Sobolev A.V., Talabanov P.G., Ryabykina G.V., Kozhemyakina E.S., Oshchepkova E.V.
Efficacy of amlodipin in treatment of arterial hypertension.
Prokhorovich E.A.
Prolonged release verapamil: application in clinical practice
Gaponova N.I., Abdrakhmanov V.R.
Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases
Dolgusheva Y.A., Agapova O.Y., Zykov K.A., Chazova I.E.
Local rigidity of the walls of the carotid artery at the site of formation of atherosclerotic plaques in patients with arterial hypertension
Vakhovskaya T.V., Tripoten M.I., Pogorelova O.A., Balakhonova T.V., Loukianov M.M., Boytsov S.A.
The effects of climate in patients with arterial hypertension, including in combination with chronic obstructive pulmonary disease and/or bronchial asthma
Chazova I.E., Ratova L.G., Dolgusheva Y.A., Nazarov B.M., Agapova O.Y., Sivakova O.A., Galitsin P.V., Rvacheva A.V., Kuznetsova T.V., Beilina V.B., Tkachev G.A., Kaznacheeva E.I., Zykov K.A.
Efficacy of metoprolol in treatment and preventive of cardiovascular diseases
Chazova I.E., Ratova L.G., Ratova L.G., Chazova I.E.
Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging
Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Perepelova E.M., Perepelov V.A.
Loop diuretics in the treatment of hypertension and edema syndrome
Kirichenko A.A.
The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions
Samorodskaya I.V., Boitsov S.A.
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan
Trukhan D.I.
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension
Tereshchenko S.N., Zhirov I.V.
Performance of the Program of prevention and treatment of arterial hypertension in Ukraine (1999-2007)
Sirenko Y.M.
Gender differences efficiency of various dosage regimes of antihypertensive agents by patients with arterial hypertension and coronary heart disease
Skibitsky V.V., Gorodetskaya E.V., Kudryashov E.A., Fendrikova A.V., Skibitsky A.V.
Achievement of the main goals of therapy by using of a triple fixed combination of amlodipine, indapamide and perindopril (Co-Dalneva®) in patients with arterial hypertension
Chukaeva I.I., Spiryakina Y.G., Glibko K.V., Orlov D.A., Bayramova A.S., Logunova I.Y.
Predictors of progression of atrial fibrillation in patients with arterial hypertension
Podzolkov V.I., Tarzimanova A.I.
Autoregulation hemodynamics in pregnancies complicated by hypertensive disorders
Makarov R.A., Kinzhalova S.V., Davydova N.S.
Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat
Chazova I.E., Ageev F.T., Smirnova M.D., Ageeva N.V., Fofanova T.V., Svirida O.N., Mikhailov G.V., Levin A.M., Revich B.A.
B-ADRENOBLOCKERS IN THERAPY FOR ARTERIAL HYPERTENSION: ON THE WAY TO REASONABLE COMPROMISE
Perepech N.B., Shurygina V.D.
Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience
Savelyeva N.Y., Zherzhova A.Y., Mikova E.V., Gapon L.I., Kolunin G.V., Krinochkin D.V.
Prevention of cardiovascular events at patients with arterial hypertension at treatmentangiotensin-converting enzyme inhibitor.
Kislyak O.A., Postnikova S.V.
Control of cardiovascular risk in patients with diabetes
Zhernakova Y.V., Chazova I.E.
Dependence of the efficiency of the initial state of fosinopril structure common carotid arteries, intravascular blood flow and central hemodynamics at patients with arterial hypertension
Melnikova L.V., Bartosh L.F., Grechishkina O.A.
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
Baryshnikov G.A., Stepanova I.I., Kudryavtseva N.A.
Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy
Barbarash O.L., Kashtalap V.V.
Consensus on patients with hyperuricemia and high cardiovascular risk treatment
Chazova I.E., Zhernakova J.V., Kisliak O.A., Nedogoda S.V., Podzolkov V.I., Oshchepkova E.V., Medvedeva I.V., Mironova O.I., Blinova N.V.
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity
Zheleznova E.A., Zhernakova Y.V., Chazova I.E., Rogoza A.N., Zairova A.R., Shariya M.A., Yarovaya E.B., Orlovsky A.A., Blinova N.V., Azimova M.O., Gorieva S.B., Konosova I.D.
Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension
Alekseeva T.A., Litvin A.Y.
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
Chazova E.E., Martyniuk T.V.
The benefits of candesartan usage in the treatment of arterial hypertension
Ostroumova O.D., Bondarets O.V., Guseva T.F.
Factors influencing compliance with lifestyle modification in an organized population
Alekseeva T.S., Ogarkov M.Y., Skripchenko A.E., Yankin M.Y.
Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study)
Chazova I.E., Ratova L.G.
Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion
Litvin A.Y., Elfimova E.M., Chazova I.E.
«New» molecules composed of rational combinations of antihypertensive drugs: issues of choice
Kislyak O.A., Chervyakova Y.B.
National questionnaire of treatment compliance:testing and application in outpatient practice
Fofanova T.V., Ageev F.T., Smirnova M.D., Svirida O.N., Kuzmina A.E., Thostov A.S., Nelyubina A.S.
The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
Nedogoda S.V., Ledyaeva A.A., Chumachok E.V., Tsoma V.V., Salasyuk A.S.
Target blood pressure levels in patients with arterial hypertension and frailty
Ostroumova O.D., Cherniaeva M.S., Morozov A.P.
The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
Baryshnikova G.A., Baryshnikova G.A.
Pulmonary hypertension: reasonable selection of specific therapy
Karoli N.A., Sazhnova S.I., Rebrov A.P.
A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
Ageev F.T., Smirnova M.D., Fofanova T.V., Blankova Z.N., Vitsenya M.V., Tsybulskaya T.V., Neverova E.F., Samsonova N.S.
The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia
Shishkova V.N.
Rational pharmacotherapy of hypertension. Urapidil potential
Morozova T.E., Andruschishina T.B., Shmarova D.G.
Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article]
Blinova E.V., Sakhnova T.A., Chaykovskaya O.Y., Saidova M.A., Ryabykina G.V.
Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy
Avalyan A.A., Oshchepkova E.V., Saidova M.A., Shitov V.N., Glazkova E.V., Stenina M.B., Chazova I.E.
1 - 100 of 223 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies